دورية أكاديمية

Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform

التفاصيل البيبلوغرافية
العنوان: Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform
المؤلفون: Sobhan, Praveen K.1, Seervi, Mahendra1, Joseph, Jeena1, Chandrika, Bhavya Balan1, Varghese, Saneesh1, Santhoshkumar, T.R. trsanthosh@rgcb.res.in, Radhakrishna Pillai, M.1
المصدر: Cancer Letters. Apr2012, Vol. 317 Issue 1, p78-88. 11p.
مصطلحات موضوعية: *CANCER treatment, *HEAT shock proteins, *ENZYME inhibitors, *DRUG resistance, *BIOLOGICAL assay, *CELL populations, *CELL differentiation, *CANCER stem cells
مستخلص: Abstract: Current cancer therapeutics are identified based on initial tumor regression screens that mostly kill differentiated tumor cells, sparing the rare cancer stem cells (CSCs). Being rare and difficult to characterize, it remains a challenge to identify compounds active against them. Side population (SP) cells identified in multiple cancer cell line panels expressing mitochondrial Cytochrome C-EGFP were evaluated for identifying possible drug candidates utilizing high-throughput imaging. We identified heat shock protein 90 inhibitors as potential agents to sensitize SP cells to anticancer drugs. Hsp90 inhibitors induced down regulation of Akt leading to proteasomal degradation of survivin and consequent mitochondrial apoptosis. A successful screening platform for identifying compounds targeting drug resistant side population cells was developed. [Copyright &y& Elsevier]
قاعدة البيانات: Academic Search Index
ResultId 1
Header asx
Academic Search Index
71336240
1204
6
Academic Journal
academicJournal
1204.33154296875
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=71336240&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Sobhan%2C+Praveen+K%2E%22">Sobhan, Praveen K.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Seervi%2C+Mahendra%22">Seervi, Mahendra</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Joseph%2C+Jeena%22">Joseph, Jeena</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Chandrika%2C+Bhavya+Balan%22">Chandrika, Bhavya Balan</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Varghese%2C+Saneesh%22">Varghese, Saneesh</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Santhoshkumar%2C+T%2ER%2E%22">Santhoshkumar, T.R.</searchLink><i> trsanthosh@rgcb.res.in</i><br /><searchLink fieldCode="AR" term="%22Radhakrishna+Pillai%2C+M%2E%22">Radhakrishna Pillai, M.</searchLink><relatesTo>1</relatesTo> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Cancer+Letters%22">Cancer Letters</searchLink>. Apr2012, Vol. 317 Issue 1, p78-88. 11p. )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22CANCER+treatment%22">CANCER treatment</searchLink><br />*<searchLink fieldCode="DE" term="%22HEAT+shock+proteins%22">HEAT shock proteins</searchLink><br />*<searchLink fieldCode="DE" term="%22ENZYME+inhibitors%22">ENZYME inhibitors</searchLink><br />*<searchLink fieldCode="DE" term="%22DRUG+resistance%22">DRUG resistance</searchLink><br />*<searchLink fieldCode="DE" term="%22BIOLOGICAL+assay%22">BIOLOGICAL assay</searchLink><br />*<searchLink fieldCode="DE" term="%22CELL+populations%22">CELL populations</searchLink><br />*<searchLink fieldCode="DE" term="%22CELL+differentiation%22">CELL differentiation</searchLink><br />*<searchLink fieldCode="DE" term="%22CANCER+stem+cells%22">CANCER stem cells</searchLink> )
Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => Abstract: Current cancer therapeutics are identified based on initial tumor regression screens that mostly kill differentiated tumor cells, sparing the rare cancer stem cells (CSCs). Being rare and difficult to characterize, it remains a challenge to identify compounds active against them. Side population (SP) cells identified in multiple cancer cell line panels expressing mitochondrial Cytochrome C-EGFP were evaluated for identifying possible drug candidates utilizing high-throughput imaging. We identified heat shock protein 90 inhibitors as potential agents to sensitize SP cells to anticancer drugs. Hsp90 inhibitors induced down regulation of Akt leading to proteasomal degradation of survivin and consequent mitochondrial apoptosis. A successful screening platform for identifying compounds targeting drug resistant side population cells was developed. [Copyright &y& Elsevier] )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1016/j.canlet.2011.11.009 ) ) [Languages] => Array ( [0] => Array ( [Code] => eng [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 11 [StartPage] => 78 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => CANCER treatment [Type] => general ) [1] => Array ( [SubjectFull] => HEAT shock proteins [Type] => general ) [2] => Array ( [SubjectFull] => ENZYME inhibitors [Type] => general ) [3] => Array ( [SubjectFull] => DRUG resistance [Type] => general ) [4] => Array ( [SubjectFull] => BIOLOGICAL assay [Type] => general ) [5] => Array ( [SubjectFull] => CELL populations [Type] => general ) [6] => Array ( [SubjectFull] => CELL differentiation [Type] => general ) [7] => Array ( [SubjectFull] => CANCER stem cells [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Identification of heat shock protein 90 inhibitors to sensitize drug resistant side population tumor cells using a cell based assay platform [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Sobhan, Praveen K. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Seervi, Mahendra ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Joseph, Jeena ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chandrika, Bhavya Balan ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Varghese, Saneesh ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Santhoshkumar, T.R. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Radhakrishna Pillai, M. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 04 [Text] => Apr2012 [Type] => published [Y] => 2012 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 03043835 ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 317 ) [1] => Array ( [Type] => issue [Value] => 1 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Cancer Letters [Type] => main ) ) ) ) ) ) )
IllustrationInfo